WT
BIO icon

Washington Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Washington Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16
Closed -$3.9K – 301
2025
Q1 		$3.9K Hold
16
– – ﹤0.01% 678
2024
Q4 		$5.26K Sell
16
-1
-6% -$339 ﹤0.01% 730
2024
Q3 		$5.69K Buy
17
+1
+6% +$318 ﹤0.01% 725
2024
Q2 		$4.37K Buy
16
+5
+45% +$1.45K ﹤0.01% 756
2024
Q1 		$3.81K Hold
11
– – ﹤0.01% 767
2023
Q4 		$3.55K Buy
+11
New +$3.45K ﹤0.01% 748
2023
Q1 		– Sell
-78
Closed -$32.8K – 958
2022
Q4 		$32.8K Buy
78
+30
+63% +$12.1K ﹤0.01% 471
2022
Q3 		$20K Buy
+48
New +$23.9K ﹤0.01% 539
2022
Q1 		– Sell
-110
Closed -$83K – 937
2021
Q4 		$83K Hold
110
– – ﹤0.01% 355
2021
Q3 		$82K Hold
110
– – ﹤0.01% 433
2021
Q2 		$71K Hold
110
– – ﹤0.01% 461
2021
Q1 		$63K Hold
110
– – ﹤0.01% 458
2020
Q4 		$64K Hold
110
– – ﹤0.01% 446
2020
Q3 		$57K Hold
110
– – ﹤0.01% 423
2020
Q2 		$48K Buy
110
+79
+255% +$34.9K ﹤0.01% 395
2020
Q1 		$11K Buy
+31
New +$11.4K ﹤0.01% 645
2018
Q3 		– Sell
-45
Closed -$13K – 291
2018
Q2 		$13K Buy
+45
New +$12.4K ﹤0.01% 635

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Washington Trust's BIO Position: Q2 2025 in Review

Washington Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 16 shares — an estimated $3.9K sold.

Washington Trust first reported a position in BIO in Q2 2018 and held it in 17 quarters. The position peaked at $83K in Q4 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Washington Trust reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 16 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $3.9K.
  • Washington Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and held it in 17 quarters.
  • Washington Trust's Bio-Rad Laboratories Class A position peaked at $83K in Q4 2021.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.